Gonzalo Rodriguez Berriguete
Recent publications
-
UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironment by regulating tumour cell fate
Preprint
Suwa T. et al, (2024)
-
Repurposing radiosensitising medicines for radiotherapy: an overview
Journal article
Low JM. et al, (2024), BMJ Oncology, 3
-
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.
Journal article
Rodriguez-Berriguete G. et al, (2024), Cell Death Dis, 15
-
Data from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Other
Rodriguez-Berriguete G. et al, (2023)
-
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.
Journal article
Rodriguez-Berriguete G. et al, (2023), Clin Cancer Res, 29, 1631 - 1642